NEW YORK and MISSISSAUGA, Ontario, July 11, 2011 /PRNewswire/ -- CardioGenics Holdings Inc. (CGNH.OB) announced today that Dr. Yahia Gawad, MB, Ch.B., MD, MSc., Director and CEO of CardioGenics, will be presenting at RetailInvestorConferences.com.DATE: July 12, 2011TIME: 2:00 PM EDTLINK:www.retailinvestorconferences.comThis will be a live, interactive online event where investors are invited to ask the company questions in real-time, both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live in real-time an on-demand archive will be available for 90 days.
It is recommended that investors pre-register to save time and receive event updates.
About CardioGenics Holdings Inc.Through its operating subsidiaries, the Company develops ultra-sensitive analyzers and other products targeting the immunoassay segment of the Point-Of-Care IVD testing market. It has developed the QL Care™ Analyzer, a proprietary and ultra-sensitive Point-Of-Care immuno-analyzer, which will run a number of diagnostic tests under development, the first of which will be a series of cardiovascular diagnostic tests. As part of its core proprietary technology, the Company has also developed a proprietary method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improve instrument sensitivity to light. The Company's proprietary microspheres technology and SAVAsphere™ magnetic beads are developed and marketed through the Company's Luxspheres subsidiary. The Company's principal offices are located in Mississauga, Ontario, Canada. For more information please visit www.cardiogenics.com and